Biomarkers /
SDHA
Overview
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (SDHA) is a gene that encodes a catalytic protein that is a member of succinate-ubiquinone oxidoreductase. The complex participates in the mitochondrial respiratory chain. Missense mutations, nonsense mutations, silent mutations, frameshift deletions, and in-frame deletions are observed in cancers such as endometrial cancer, intestinal cancer, and stomach cancer.
SDHA is altered in 2.60% of all cancers with lung adenocarcinoma, colon adenocarcinoma, breast invasive ductal carcinoma, pancreatic adenocarcinoma, and bladder urothelial carcinoma having the greatest prevalence of alterations [3].
The most common alterations in SDHA are SDHA Mutation (1.36%), SDHA Amplification (1.23%), SDHA A449V (0.52%), SDHA Loss (0.08%), and SDHA Nonsense (0.06%) [3].
Clinical Trials
Significance of SDHA in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.